Oncopeptides AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2015 - 2019
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2015 - 2019
Revenue	50.87	31.65	35.22	8.36	118.3	-	Upgrade
Revenue Growth (YoY)	138.06%	-10.14%	321.54%	-92.94%	-	-	Upgrade
Cost of Revenue	1.74	2.66	-1.08	0.01	53.12	-	Upgrade
Gross Profit	49.13	28.99	36.3	8.35	65.17	-	Upgrade
Selling, General & Admin	199.53	197.28	188.48	142.2	873.81	654.19	Upgrade
Research & Development	114.86	121.19	106.95	217.66	679.93	866.21	Upgrade
Other Operating Expenses	-5.51	-6.9	-6.34	-4.57	3.9	-	Upgrade
Operating Expenses	308.88	311.57	289.09	355.29	1,558	1,520	Upgrade
Operating Income	-259.74	-282.59	-252.79	-346.94	-1,492	-1,520	Upgrade
Interest Expense	-17.95	-12.66	-5.79	-0.88	-0.95	-1.49	Upgrade
Interest & Investment Income	8.2	8.2	8.59	2.62	0.49	0.32	Upgrade
Currency Exchange Gain (Loss)	2.84	2.84	1.54	8.96	71.54	-70.87	Upgrade
Other Non Operating Income (Expenses)	0	0	-	-	0	-	Upgrade
EBT Excluding Unusual Items	-266.66	-284.21	-248.45	-336.24	-1,421	-1,592	Upgrade
Gain (Loss) on Sale of Assets	-	-	-	-1.44	-	-	Upgrade
Pretax Income	-266.66	-284.21	-248.45	-337.68	-1,421	-1,592	Upgrade
Income Tax Expense	0.52	0.4	0.66	0.27	8.95	2.25	Upgrade
Net Income	-267.18	-284.61	-249.11	-337.95	-1,430	-1,595	Upgrade
Net Income to Common	-267.18	-284.61	-249.11	-337.95	-1,430	-1,595	Upgrade
Shares Outstanding (Basic)	212	166	90	82	75	62	Upgrade
Shares Outstanding (Diluted)	212	166	90	82	75	62	Upgrade
Shares Change (YoY)	-1.40%	84.14%	9.80%	9.33%	20.72%	20.63%	Upgrade
EPS (Basic)	-1.26	-1.71	-2.76	-4.11	-19.00	-25.57	Upgrade
EPS (Diluted)	-1.26	-1.71	-2.76	-4.11	-19.00	-25.57	Upgrade
Free Cash Flow	-325.07	-260.93	-279.61	-423.02	-1,517	-1,314	Upgrade
Free Cash Flow Per Share	-1.53	-1.57	-3.09	-5.14	-20.14	-21.06	Upgrade
Gross Margin	96.58%	91.59%	103.06%	99.93%	55.09%	-	Upgrade
Operating Margin	-510.60%	-892.91%	-717.74%	-4152.44%	-1261.64%	-	Upgrade
Profit Margin	-525.22%	-899.29%	-707.30%	-4044.90%	-1209.11%	-	Upgrade
Free Cash Flow Margin	-639.02%	-824.47%	-793.89%	-5063.03%	-1282.16%	-	Upgrade
EBITDA	-257.26	-280.12	-250.35	-344.93	-1,491	-1,519	Upgrade
D&A For EBITDA	2.49	2.47	2.44	2.01	1.72	1.72	Upgrade
EBIT	-259.74	-282.59	-252.79	-346.94	-1,492	-1,520	Upgrade

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.